--- schema_version: "secwatch.filing_event.v1" accession: "0001425450-26-000041" form_type: "8-K" ticker: "KIDS" cik: "0001425450" company_name: "ORTHOPEDIATRICS CORP" filed_at: "2026-06-04T20:22:09+00:00" generated_at: "2026-06-04T20:56:52.188132+00:00" event_type: "other" sentiment: "neutral" materiality_score: 0.2 calibrated_materiality_score: 0.15 confidence: "high" source: SEC EDGAR --- # OrthoPediatrics shareholders elect directors, approve 2.05M share increase to incentive plan ## Summary - All four director nominees elected; Dyer had 10.8M for, 8.0M withheld; others >18M for. - Advisory say-on-pay approved: 15.95M for, 2.86M against, 39.8K abstain. - Amendment to 2024 Incentive Plan approved: shares increased by 2.05M to 3.68M total. - Ratification of Deloitte as auditor approved: 20.48M for, 154K against. ## SEC filing metadata - accession: 0001425450-26-000041 - form_type: 8-K - ticker: KIDS - cik: 0001425450 - company_name: ORTHOPEDIATRICS CORP - filed_at: 2026-06-04T20:22:09+00:00 - event_type: other - sentiment: neutral - materiality_score: 0.2 - calibrated_materiality_score: 0.15 - confidence: high - sec_items: 5.07 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545026000041/0001425450-26-000041-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545026000041/kids-20260604.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001425450-26-000041 - JSON: https://secwatch.observer/filing/0001425450-26-000041.json - Plain text: https://secwatch.observer/filing/0001425450-26-000041.txt ## Key facts - Shareholder Votes ORTHOPEDIATRICS CORP shareholders approved Approval, on an advisory basis, of the compensation of the Company's named executive officers at the 2026-06-04 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2026-06-04 source text: Approval, on an advisory basis, of the compensation of the Company's named executive officers The Company's stockholders approved the compensation of the Company's named executive officers by voting as follows: For Against Abstain Broker Non-Votes 15,953,457 2,859,793 39,764 1,827,535 evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545026000041/0001425450-26-000041-index.htm - Shareholder Votes ORTHOPEDIATRICS CORP shareholders approved Approval of an amendment to the 2024 Incentive Award Plan to increase the number of shares authorized under the Plan by 2,050,000 shares, which would increase the total number of shares to 3,679,000 at the 2026-06-04 meeting. - Proposal: equity plan - Outcome: passed - Meeting: 2026-06-04 source text: Approval, of an amendment to the 2024 Incentive Award Plan ("Plan") to increase the number of shares authorized under the Plan by 2,050,000 shares, which would increase the total number of shares to 3,679,000 The Company's stockholders approved the amendment to the 2024 Incentive Award Plan by voting as follows: For Against Abstain Broker Non-Votes 18,545,409 272,115 35,490 1,827,535 evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545026000041/0001425450-26-000041-index.htm - Shareholder Votes ORTHOPEDIATRICS CORP shareholders approved Approval, on an advisory basis, of the appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for our Fiscal Year Ending December 31, 2026 at the 2026-06-04 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2026-06-04 source text: Approval, on an advisory basis, of the appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for our Fiscal Year Ending December 31, 2026 The Company’s stockholders approved the appointment by the Audit Committee of the Company’s Board of Directors of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 by voting as follows: For Against Abstain 20,479,183 154,131 47,235 evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545026000041/0001425450-26-000041-index.htm - Shareholder Votes ORTHOPEDIATRICS CORP shareholders approved Election of Directors at the 2026-06-04 meeting. - Proposal: director election - Outcome: passed - Meeting: 2026-06-04 source text: Election of Directors The nominees below were elected to serve as directors for a term that will last until the Company’s 2029 Annual Meeting of Stockholders or until his or her successor is duly elected and qualified. The number of votes cast for and withheld from each nominee and the number of broker non-votes with respect to each nominee were as follows: Name Votes For Votes Withheld Broker Non-Votes George S. M. Dyer 10,843,747 8,009,267 1,827,535 Kelly Fischer 18,535,024 317,990 1,827,535 David R. Pelizzon 18,056,773 796,241 1,827,535 Harald Ruf 18,077,260 775,754 1,827,535 evidence_url: https://www.sec.gov/Archives/edgar/data/1425450/000142545026000041/0001425450-26-000041-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.